Adoa News Adoa News
Related Articles
The fourth edition of the International AIDS Society (IAS) Digest centres on the theme, Advancing Prevention. It brought updates from IAS programmes on the pressing issues around HIV prevention, impacting people affected by and working on HIV today. It features IAS-led sessions from HIVR4P 2024, the 5th HIV Research for Prevention Conference, held in Lima, Peru, from 6 to 10 October 2024.
The event afforded IAS President Beatriz Grinsztejn to reflect on the critical role of prevention in ending the HIV pandemic.
Click the link below for her full message.
Takeaways from HIVR4P 2024
About 1,300 scientists, advocates, community representatives, and policy makers came together in Lima and virtually to share and explore the latest evidence and emerging tools from HIV prevention science.
The conference also highlighted the advancement of long-acting HIV prevention options, PEP and PrEP implementation, the importance of choice, and HIV vaccine R&D and bNAbs in HIV prevention.
Read the full takeaways here:
https://www.iasociety.org/blog/takeaways-hivr4p-2024#msdynttrid=XgzV-BjXObUkx8ZbVt3JhW5DxwFtCT27TgyVkltwHxQ
The Global HIV Vaccine Enterprise
Connections between prevention and cure research are coming to the fore and could support the dual goals of HIV prevention and eradication. This was underlined at the Global HIV Vaccine Enterprise’s satellite session, “Beyond Prevention: Harnessing HIV Vaccines for an HIV Cure”, at HIVR4P 2024.
Highlighting breakthroughs in HIV vaccine research, the Enterprise, in collaboration with Scripps Research Institute, hosted a webinar titled “Cutting-edge developments in HIV vaccine research: New insights and implications”. It explored recent progress in inducing bNAbs and underscored the scientific community’s ongoing commitment to innovative HIV vaccine development.
Corporate Partnership Programme
Amid pressing challenges in global HIV prevention, complex patent landscapes create barriers that often delay vaccine development, a Corporate Partnership Programme and Global HIV Vaccine Enterprise satellite, “Understanding and managing intellectual property for HIV vaccine research and development”, emphasized. The session called for improved access to essential technology.
Industry leaders discussed collaborative strategies to boost PrEP access across South America in the session, “Enhancing service providers’ engagement in PrEP delivery, uptake, and retention in Latin America & the Caribbean”, focusing on stronger partnerships with local healthcare providers.
Educational Fund
Since January 2024, the IAS Educational Fund has held key meetings in Moldova, Trinidad and Tobago, Tunisia, the Philippines and Pakistan, with a strong emphasis on HIV prevention, a priority across all regions.
These convenings, contextualized for local needs, are intended to drive improvements in strategies, policies and clinical practices in the HIV response that align with the latest scientific evidence.
Journal of the International AIDS Society (JIAS)
The Journal of the International AIDS Society (JIAS) published an abstract supplement for HIVR4P 2024, which includes all oral abstracts from the conference and features interdisciplinary studies on HIV prevention strategies.
JIAS also announced the winners of the JIAS HIV Prevention Impact Award 2024 at HIVR4P 2024. The award recognizes one high-impact publication from 2023 with a focus on HIV prevention, determined by the votes of the journal’s Editorial Board members and Deputy Editors.
Story by Reginald Pepsival Robertson
Credit: IAS Comms
